Atherosclerosis is a progressive disorder initiated by biomechanical forces in areas of the vascular tree subjected to disturbed blood flow and a number of systemic factors, including hyperlipidemia, smoking, and diabetes (1, 2). Lipid uptake by the vascular wall leads over time to a gradual buildup of atherosclerotic plaques. Once formed, the plaque continues to expand, leading to a gradual restriction in lumen diameter and compromise of blood flow. Under certain conditions, plaque rupture can precipitate intravascular thrombosis, resulting in complete and sudden interruption of the arterial blood supply. The buildup, growth, and rupture of the plaque have all been associated with the presence of systemic and vascular wall inflammation (3-5). Despite strong data linking vessel wall inflammation to atherosclerosis progression, the mechanism(s) of inflammation-induced atherosclerotic disease progression remains obscure (4), while efforts to halt disease progression by antiinflammatory therapies have failed in clinical trial (3).
Introduction
Atherosclerosis is a progressive disorder initiated by biomechanical forces in areas of the vascular tree subjected to disturbed blood flow and a number of systemic factors, including hyperlipidemia, smoking, and diabetes (1, 2) . Lipid uptake by the vascular wall leads over time to a gradual buildup of atherosclerotic plaques. Once formed, the plaque continues to expand, leading to a gradual restriction in lumen diameter and compromise of blood flow. Under certain conditions, plaque rupture can precipitate intravascular thrombosis, resulting in complete and sudden interruption of the arterial blood supply. The buildup, growth, and rupture of the plaque have all been associated with the presence of systemic and vascular wall inflammation (3) (4) (5) . Despite strong data linking vessel wall inflammation to atherosclerosis progression, the mechanism(s) of inflammation-induced atherosclerotic disease progression remains obscure (4) , while efforts to halt disease progression by antiinflammatory therapies have failed in clinical trial (3) .
Recent studies have documented a high incidence of endothelial-to-mesenchymal transition (EndMT) in a number of pathological conditions associated with inflammation, such as myocardial infarction (6) , cerebral cavernous malformations (7), portal hypertension (8) , pulmonary hypertension (9) , and vascular graft failure (10, 11) among others. EndMT is characterized by a change in phenotype of normal endothelial cells (ECs) that assume the shape and properties of mesenchymal cells (fibroblasts, smooth muscle cells [SMCs] ), including enhanced proliferation and migration; secretion of extracellular matrix proteins, such as fibronectin and collagen; and expression of various leukocyte adhesion molecules.
TGF-β has been identified as the central player in driving EndMT progression (12, 13) , but the processes leading to activation of its signaling remain poorly defined. We have previously reported that a reduction in endothelial FGF-mediated signaling induced by knockout of either the key intracellular signal mediator FGF receptor substrate 2 α (FRS2α) (10) or the primary FGF receptor in the endothelium (FGF receptor 1 [FGFR1]) (14) activates TGF-β signaling, leading to EndMT.
The unusual feature of FGFR1 biology is that FGFR1's expression in ECs is affected by certain inflammatory stimuli, including IFN-γ, TNF-α, and IL-1β, that induce a profound reduction in its expression (10) . Since these are precisely the inflammatory mediators found in atherosclerotic plaques, we set out to investigate the occurrence and role of EndMT in atherosclerosis.
Studies in cell culture and mouse models demonstrated that both oscillatory fluid shear stress and soluble inflammatory mediators reduced FGFR1 expression and signaling and promoted TGF-β signaling and EndMT. In addition, analysis of human coronary arteries demonstrated a strong correlation among endothelial FGFR1 expression, increased TGF-β signaling, and the appearance of EndMT with the severity of atherosclerosis. Together, these findings point to a mechanism whereby biomechanical and soluble inflammatory stimuli reduce protective endothelial FGFR1 signaling to drive EndMT and progression of atherosclerotic plaque.
The molecular mechanisms responsible for the development and progression of atherosclerotic lesions have not been fully established. Here, we investigated the role played by endothelial-to-mesenchymal transition (EndMT) and its key regulator FGF receptor 1 (FGFR1) in atherosclerosis. In cultured human endothelial cells, both inflammatory cytokines and oscillatory shear stress reduced endothelial FGFR1 expression and activated TGF-β signaling. We further explored the link between disrupted FGF endothelial signaling and progression of atherosclerosis by introducing endothelial-specific deletion of FGF receptor substrate 2 α (Frs2a) in atherosclerotic (Apoe -/-) mice. When placed on a high-fat diet, these double-knockout mice developed atherosclerosis at a much earlier time point compared with that their Apoe -/-counterparts, eventually demonstrating an 84% increase in total plaque burden. Moreover, these animals exhibited extensive development of EndMT, deposition of fibronectin, and increased neointima formation. Additionally, we conducted a molecular and morphometric examination of left main coronary arteries from 43 patients with various levels of coronary disease to assess the clinical relevance of these findings. The extent of coronary atherosclerosis in this patient set strongly correlated with loss of endothelial FGFR1 expression, activation of endothelial TGF-β signaling, and the extent of EndMT. These data demonstrate a link between loss of protective endothelial FGFR signaling, development of EndMT, and progression of atherosclerosis.
FGFR1 expression and an increase in EndMT markers (Supplemental Figure 2 ; see complete unedited blots in the supplemental material) that was similar to results observed with shRNA-mediated suppression of FGF signaling described above. To more fully characterize this response, HUVECs were treated with optimal doses of the 3 cytokines, alone or in combination. The cytokineinduced reduction in FGFR1 expression was most pronounced when IFN-γ, TNF-α, and IL-1β were used together (Supplemental Figure 3B ; see complete unedited blots in the supplemental material). On their own, none of the cytokines induced a reduction in expression of endothelial markers, such as vascular endothelial-cadherin (VE-cadherin) or VEGFR2. However, cytokine combinations profoundly reduced expression of these proteins (Supplemental Figure 3B ; see complete unedited blots in the supplemental material). Similarly, an increase in TGF-β receptor 1 (TGF-βR1) expression, a key step in EndMT induction, was most pronounced when any 2 of the 3 cytokines were present (Supplemental Figure 3A) . Finally, induction of EndMT in ECs in vitro resulted in a marked upregulation of mesenchymal markers (ZEB2, SLUG, SNAIL, vimentin, and collagen 1), smooth muscle marker (SM22α), leukocyte adhesion molecules (ICAM-1 and VCAM-1), monocyte
Results
Inflammatory cytokines, shear stress, and EndMT. Inflammation and shear stress play important roles in the development and progression of atherosclerotic lesions. Previous studies have identified FGFR1 expression as a key regulator of TGF-β-induced EndMT (14) and demonstrated that certain inflammatory cytokines could reduce FGFR1 levels, thereby reducing FGF signaling (10) . To test the link between the extent of reduction in FGF signaling, FGFR1 expression, and cytokines, we first studied the relationship between the reduction in FGFR1, or its key intracellular signaling mediator FRS2α expression, and activation of TGF-β signaling and the appearance of EndMT. When exposed to progressively higher doses of FGFR1 or FRS2α shRNA-encoding lentiviruses, HUVECs exhibited a dose-dependent decline in target gene expression, an increase in phosphorylation of TGF-β signaling intermediary SMAD2 (p-SMAD2), and the appearance of EndMT markers collagen 1, vimentin, and SM22α (Supplemental Figure 1 ; see complete unedited blots in the supplemental material; supplemental material available online with this article; doi:10.1172/JCI82719DS1).
HUVECs were next treated with increasing concentrations of IFN-γ, TNF-α, or IL-1β. All 3 cytokines induced a decrease in Atherosclerotic plaques preferentially develop in regions of arteries characterized by oscillating shear stress (OSS), in contrast to high laminar shear stress (LSS), which is atheroprotective. We therefore examined the effect of OSS and LSS on FGFR1 expression and TGF-β signaling in HUVECs. When exposed to 16 hours of OSS, HUVECs demonstrated a significant reduction in FGFR1 expression, while a similar duration of exposure to LSS increased it ( Figure  1A ). Staining for SMAD2/3 demonstrated increased translocation of these proteins to nuclei of HUVECs exposed to OSS, but not LSS, a finding consistent with activation of TGF-β signaling by OSS ( Figure  1B ). In addition, OSS, but not LSS, induced a significant increase in mRNA levels of the transcription factor TWIST1 ( Figure 1C ), which has been reported to be involved with TGF-β signaling (11, 15) . In agreement with this activation of the EndMT program, there was an increase in expression of SMC markers (ACTA2, which encodes smooth muscle α-actin, and NOTCH3) ( Figure 1D ) and mesenchymal markers (N-cadherin, fibronectin 1, and collagen 1A) ( Figure 1E ). thoracic and abdominal aorta, aortic root, and brachiocephalic arteries ( Figure 6 , A-C). The total plaque burden in the aorta was approximately 84% larger than that in Apoe -/-mice (17.82% in Apoe -/-vs. 32.79% in FRS2α ECKO Apoe -/-) ( Figure 6A ). Increases in the lesion area were equally significant in the aortic root, brachiocephalic artery, and abdominal aorta ( Figure 6 , B, C, and E). Histologic examination of the abdominal aorta demonstrated very extensive circumferential plaque in double-knockout animals that covered normally atheroresistant areas that was never observed in Apoe -/-mice ( Figure 6D ). Furthermore, there was a significant increase in the size of the necrotic core and a decrease in the size of the fibrous cap ( Figure 6 , D and F), features typical of the vulnerable plaque.
Immunocytochemistry demonstrated extensive circumferential expression of ICAM-1 and VCAM-1 and the recruitment of monocytes/macrophages ( Figure 7 , A, B, D, and E). In addition, atherosclerotic lesions of FRS2α ECKO Apoe -/-mice stained strongly for activated TGF-β signaling (p-SMAD2), smooth muscle α-actin, and NOTCH3 expression and extensive collagen and fibronectin deposition (Supplemental Figure 6 and Figure 7 , C and F), all markers for EndMT. Examination of brachiocephalic arteries produced similar findings (Supplemental Figure 7) .
EndMT in human atherosclerosis. To investigate EndMT in human atherosclerosis, immunofluorescence microscopy was used to examine the left main coronary arteries (Supplemental To further examine the role of endothelial FGF signaling in atherosclerotic lesion development, we generated mice with inducible endothelium-specific deletion of the gene encoding the pan-FGFR adaptor molecule FRS2α on an endothelial fate-mapped Apoe -/-background using a Cdh5-CreER T2 driver (16 Figure 5A ). Tamoxifen was injected postnatally, and the efficiency of fate mapping and FRS2α excision in FRS2α
ECKO Apoe -/-mice was determined by immunocytochemical examination of aortas (Supplemental Figure 5B ) and Western blotting (Supplemental Figure 5C ; see complete unedited blots in the supplemental material). Body weight, total cholesterol, and triglyceride and HDL cholesterol levels in FRS2α
ECKO Apoe -/-mice were no different from those in Apoe -/-mice before and after 16 weeks of HFD (Supplemental Figure 5 , D and E).
Examination of the aortic arch, thoracic and abdominal aorta, and aortic root after 4 weeks of HFD revealed more extensive atherosclerotic lesions in FRS2α
ECKO Apoe -/-mice compared with Apoe -/-mice ( Figure 4 ). In addition, FRS2α ECKO Apoe -/-aortas showed increased atherosclerotic plaque lesions, deposition of fibronectin, and elevated expression of ICAM-1 and VCAM-1 in both atherosclerosis-prone and -resistant areas that were not seen in Apoe -/-mice ( Figure 5 ). After 16 weeks of HFD, FRS2α
ECKO Apoe -/-mice developed extensive atherosclerotic plaques, involving the aortic arch, There was a strong inverse linear relationship between the I/M ratio and number of ECs expressing FGFR1 (r = -0.84, P < 0.0001 Figure 8E ) and an equally strong positive correlation with the number of ECs expressing p-SMAD2 (r = 0.83, P < 0.0001, Figure 8F) . Finally, FGFR1 expression was inversely correlated with TGF-β signaling (r = -0.78, P < 0.0001, Figure 8G ). We next examined the EndMT markers NOTCH3 and SM22α in this patient cohort. While essentially no luminal coronary ECs expressed these proteins in the absence of disease, their prevalence increased significantly with disease severity, with virtually all ECs in the left main arteries from patients with severe CAD showing strong staining ( Figure 9, A-D) . Quantitative analysis of the entire patient cohort demonstrated a strong correlation between the number of ECs expressing NOTCH3 and SM22α and the I/M ratio once the prevalence of transformed ECs approached approximately 35% (r = 0.88 and 0.75, respectively; P < 0.0001, Figure 9 , E and F).
The extracellular matrix proteins collagen and fibronectin are well-recognized markers of epithelial-to-mesenchymal transition and EndMT and play important roles in atherosclerotic plaque progression. Their expression by ECs in this patient population also strongly correlated with increasing I/M ratio ( Figure 10 , A-D), and there was a strong linear relationship between increasing endothelial expression of collagen and fibronectin and disease severity ( Figure 10 , E and F). In addition, immunostaining demonstrated increasing luminal endothelial expression of ICAM-1 and VCAM-1, with increasing CAD severity ( Figure 11, A-D) . There was a strong correlation between increase in fibronectin deposition and ICAM-1 and VCAM-1 expression ( Figure 11 , E and F). These observations establish an association between the severity of CAD and loss of endothelial FGFR1 expression as well as between activation of endothelial TGF-β signaling and the extent of EndMT.
Discussion
The results of this study suggest that EndMT serves as the link between factors initiating atherosclerosis, such as inflammation and disturbed shear and the tissue remodeling that leads to plaque formation. The initiating event is the loss of protective endothelial FGF signaling input induced by OSS and vessel wall inflammation. This results in activation of endothelial TGF-β signaling and induction of EndMT. Once induced, EndMT promotes further plaque growth by increasing deposition of fibronectin, a known proatherogenic ECM protein (17, 18) , and increasing endothelial expression of adhesion molecules, such as ICAM and VCAM, thereby further promoting recruitment of circulating monocytes and leukocytes and inducing formation of new mesenchymal cells, leading to expansion of neointima.
A number of observations support this hypothesis. First, ECs downregulated FGFR1 expression and activated TGF-β signaling when exposed to OSS or certain inflammatory mediators. Second, mice with endothelial-specific disruption of FGF signaling input developed EndMT and exhibited early and extensive development of atherosclerosis when crossed onto the Apoe -/-back- 
tured ECs in vitro to OSS, but not atheroprotective LSS, results in a decrease in FGFR1 expression and an increase in p-SMAD2. Interestingly, in vivo, there were no differences in endothelial FGFR1 levels in atheroprotected and atheroprone endothelium in mice on normal chow diet. However, HFD induced a much more significant reduction in FGFR1 levels in the atheroprone endothelium.
Inflammation is an important part of atherogenesis. Studies over the last decade have documented the presence of monocytederived macrophages, T cells, B cells, and other immune mediators in atherosclerotic lesions (19) (20) (21) . This inflammatory milieu is thought to be due to a combination of factors, including mechanical factors, such disturbed shear stress (2) and lipid-induced changes in the vascular wall. With regard to the former, a number of studies have linked disturbed shear stress and endothelial production of fibronectin (17, 22) , a well-established marker of epithelial-to-mesenchymal transition (23, 24) . Fibronectin has a major role in promoting inflammatory signaling in ECs (2, 21), and multiple studies in mice demonstrate a causal role for fibronectin ground. Third, analysis of human left main coronary arteries from patients with various extents of atherosclerosis demonstrated a strong inverse correlation between the extent of coronary endothelial FGFR1 expression, the appearance of p-SMAD2 signal, and EndMT and the severity of CAD in patients. Taken together, these results establish a link between inflammation, shear stress, the loss of protective endothelial FGF signaling input, and the induction of EndMT that, in turn, plays an important role in development and growth of atherosclerotic lesions.
The strong correlation we observed between the decline in endothelial FGFR1 expression and the extent of EndMT in atherosclerotic lesions is in agreement with the previous demonstration of a protective role of endothelial FGF signaling (10, 14) . The two key factors regulating endothelial FGFR1 expression, disturbed shear stress and vessel wall inflammation, are also well-known atherosclerosis risk factors (1, 5) . However, the link between disturbed shear stress and endothelial FGFR1 expression has not previously been reported. In this study, we show that exposure of cul- TNF-α (4). The pathogenic role of IFN-γ in atherosclerosis is further demonstrated by its ability to induce lesion progression (28, 29) , while its deficiency leads to a marked reduction in lesion size while not affecting the overall lipid profile (30) . Similarly, activation of natural killer cells, also found in human atheroma lesions (19) , results in secretion of IFN-γ and TNF-α. Thus, the atheroma is rich in inflammatory mediators and exhibits evidence of chronic activation of various inflammatory pathways. While the link between inflammation and atherosclerosis is well established, the molecular underpinning of this connection remains poorly described. We propose that EndMT provides one such potential link. The ongoing inflammation, as well as disin promoting atherosclerosis (18, 25) . Fibronectin production as a consequence of EndMT therefore appears to be one mechanism by which this process promotes inflammation and atherosclerosis.
At the same time, cholesterol crystal formation in lipid-loaded macrophages in the forming atheroma can lead to activation of the inflammasome, thereby promoting conversion of pro-IL-1β into an active cytokine (26) . The preponderance of the M1 subset of macrophages in the atherosclerotic lesions (27) provides further evidence of the presence of inflammation, as these macrophages are thought be derived from monocytes in response to stimulation with IFN-γ. The latter is likely produced by T cells that in human lesions exhibit a Th1 secretion profile that includes IFN-γ and Reduction of inflammation has recently become the key target in the development of new antiatherosclerotic therapies. Various attempts to suppress specific aspects of inflammation, including an IL-1β-neutralizing antibody (CANTOS) (31), have been equivocal at best. Yet, the emerging biology of EndMT suggests that approaches targeting individual inflammatory pathways are likely to fail, since any of the "big 3" cytokines found in the plaque -IFN-γ, IL-1β, and TNF-α -can induce EndMT and, hence, lead to atherosclerotic disease progression. In contrast, restoration of effective endothelial FGF signaling and/or suppression of endothelial TGF-β signaling may effectively halt the disease progression. The latter points to the complexity of endothelial biology, as smooth muscle TGF-β signaling has been linked to reduction in atherogenesis (32, 33) and may explain the ambiguous nature of TGF-β effects in atherosclerosis (34) . turbed shear stress, decrease endothelial FGFR1 expression, leading to activation of TGF-β signaling, thereby inducing EndMT. The latter is responsible for a number of proatherogenic consequences, including increased expression of adhesion molecules, such as ICAM-1 and VCAM-1, thus promoting a further influx of inflammatory cells; deposition of extracellular matrix, such as fibronectin, that potentiates inflammation, thus accelerating atheroma growth; and, finally, the appearance of new mesenchymal cells that give rise to SMCs and fibroblasts in the neointima, further promoting plaque expansion. The proinflammatory phenotype of ECs undergoing EndMT establishes a feed-forward loop that further aggravates inflammation and leads to the ongoing plaque growth. Suppression of this process may be the key step in halting the progression of atherosclerosis. supplemented with 20% FBS (Sigma-Aldrich), l-glutamine (Gibco), and penicillin/streptomycin (Gibco). Human coronary aortic SMCs (HCASMCs) (C-017-5C), media (M231-500), and supplements (SMGS, S-007-25; SMDS, S-008-5) were purchased from Life Technologies. The cells were grown at 37°C, 5% CO 2 , in Medium 231 (Life Technologies), supplemented with smooth muscle growth supplement (SMGS containing 4.9% FBS, 2 ng/ml FGF2, 0.5 ng/ml EGF, 5 ng/ml heparin, 2 μg/ml IGF-1, and 0.2 μg/ml BSA). For SMC differentiation, HCASMCs were incubated with Medium 231 containing smooth muscle differentiation supplement (SMDS containing 1% FBS and 30 g/ml heparin) for 8 days. For different cytokine treatment, HUVECs or In summary, EndMT, induced by inflammatory components of the atheroma, potentiates the inflammatory milieu of atherosclerotic lesions and leads to progressive growth of the atherosclerotic plaque. Interventions aimed at controlling this process will test its role in progression of atherosclerosis and may, if successful, offer effective new approaches to reversing the natural history of this disease.
Methods
Cell culture and reagents. HUVECs (passage 5-10; CC-2517, Lonza) were cultured in endothelial basal medium-2, supplemented with the EGM-2MV BulletKit (CC-3202, Lonza), or in M199 with ECGS, Figure 10 . Mesenchymal marker expression in the endothelium of human coronary arteries. Left main coronary arteries from patients with no/mild (n = 10), moderate (n = 15), and severe (n = 18) CAD were evaluated. (A and C) Representative images of immunofluorescence staining of left main coronary arteries for CD31 (green), collagen 1 (red), and fibronectin (red) in patients. Nuclei were stained with DAPI (blue). Scale bar: 16 μm. (B) Measurement of the collagen 1 area in the neointima per field (*P < 0.05 compared moderate disease to no/mild disease; ***P < 0.001 compared severe disease to no/mild disease; 1-way ANOVA with Newman-Keuls post-hoc test for multiple comparison correction). (D) Ratio of fibronectin area to CD31 area per field in the lumen (*P < 0.05 compared moderate disease to no/mild disease; ***P < 0.001 compared severe disease to no/mild disease; 1-way ANOVA with Newman-Keuls post-hoc test for multiple comparison correction). (E and F) Scatter plots of collagen 1 area in the neointima per field and the ratio of fibronectin area to CD31 area per field in the lumen and the I/M ratio. The corresponding Spearman's correlation coefficient (r) between collagen 1 area in the neointima per field and the ratio of fibronectin area to CD31 area per field and the I/M ratio and the P value are shown. jci.org Volume 125 Number 12 December 2015 SMAD2/3 translocation assay. Cells were fixed with 4% formaldehyde for 15 minutes and then permeabilized with 1% Triton X-100 for 15 minutes. After permeabilization, cells were blocked with StartingBlock Blocking Buffer (Thermo Fisher Scientific) for 15 minutes and incubated overnight at 4°C with a SMAD2/3 primary antibody diluted in StartingBlock Blocking Buffer (1:500, Cell Signaling). After 3 washing steps, cells were probed with DAPI and Alexa Fluor 647-conjugated secondary antibody (1:500, Molecular Probes) diluted in StartingBlock Blocking Buffer for 2 hours at room temperature. Cells were then mounted with Fluoromount-G Mounting Media (Southern Biotech). Fifty images were then captured with a ×20 objective mounted on a Perkin Elmer spinning disk confocal microscope equipped with HCASMCs were treated with human IFN-γ (300-02, PeproTech), human TNF-α (300-01A, Peprotech), or human IL-1β (200-01B, Peprotech) in complete growth medium or in differentiation medium.
Fluid shear stress. HUVECs were seeded on tissue culture plastic slides coated with 10 μg/ml fibronectin and grown to confluence in M199 culture media supplemented with 20% FBS, ECGS, 100 mg/l heparin, and penicillin/streptomycin. Cells were starved in M199 media supplemented with 8% FBS 4 hours prior stimulation. Slides were then clamped into a parallel plate flow chamber and sheared at 12 dynes/cm 2 (laminar flow) or 1 ± 4 dynes/cm 2 (oscillatory flow) for 16 or 48 hours. Cells were then washed in PBS and further processed for immunostaining or mRNA extraction. Generation of mice. Frs2a fl/fl mice were previously described (36) . Figure 5 , D and E). PCR genotyping analysis was done using the following primers: Frs2a fl/fl (5′-GAGTGTGCTGTGATTG-GAAGGCAG-3′ and 5′-GGCACGAGTGTCTGCAGACACATG-3′), mT/mG (5′-CTCTGCTGCCTCCTGGCTTCT-3′, 5′-CGAGGCG-GATCACAAGCAATA-3′, and 5′-TCAATGGGCGGGGGTCGTT-3′), Cdh5-CreER T2 (5′-GCCTGCATTACCGGTCGATGCAACGA-3′ and 5′-GTGGCAGATGGCGCGGCAACACCATT-3′), Apoe (5′-GCCTAGC-CGAGGGAGAGCCG-3′, 5′-GTGACTTGGGAGCTCTGCAGC-3′, and 5′-GCCGCCCCGACTGCATCT-3′).
Immunohistochemical staining. Blocks were sectioned at 5-μm intervals using a Microm cryostat (for frozen blocks) or a Paraffin Microtome (for paraffin blocks). For frozen tissue sections, slides were fixed in acetone for 10 minutes at -20°C. For paraffin sections, slides were dewaxed in xylene, boiled for 20 minutes in citrate buffer (10 mM, pH 6.0) for antigen retrieval, and rehydrated. After washing 3 times with PBS, tissue sections were incubated with primary antibodies diluted in blocking solution (10% BSA and horse serum in PBS) overnight at 4°C in a humidified chamber. Sections were washed 3 times with Tris-buffered saline; incubated with appropriate Alexa Fluor 488-, Alexa Fluor 594-, or Alexa Fluor 647-conjugated secondary antibodies diluted 1:1,000 in blocking solution for 1 hour at room temperature; washed again 3 times, and mounted on slides with ProLong Gold Mounting Reagent with DAPI (P36935, Life Technologies). All immunofluorescence micrographs were acquired using a Axiovert a motorized stage (Prior Scientific). Images were then analyzed with a proprietary MATLAB function as described previously (35) . Briefly, masks of the images were made using a combination of an adaptive histogram equalization algorithm with intensity and size thresholding. Cell orientation was calculated by taking the masks of the cell nuclei (determined from DAPI images), fitting them to an ellipse, and determining the angle between the flow direction and the major axis of the ellipse. Nuclei eccentricity was measured on the basis of the eccentricity of the fitted ellipse. Nuclear translocation was computed by taking the mask of the transcription factor stain (SMAD2/3), calculating the product of both the area and the intensity of the stain present in the nucleus, and dividing it by the product of the total stain area and the total intensity of the stain. This yields a unitless metric we termed the translocation factor, which equals 1 in cells with complete nuclear translocation and 0 in cells with no translocation.
Generation of lentiviruses. The human FGFR1 shRNA lentiviral construct was purchased from Sigma-Aldrich and the human FRS2α shRNA lentiviral construct was purchased from Open Biosystems. For the production of shRNA lentivirus, 3.7 μg Δ8.2, 0.2 μg VSVG, and 2.1 μg pLKO.1 carrying the control, FGFR1, and FRS2α shRNA were cotransfected into 293T cells using X-tremeGENE 9 DNA Transfection Reagent (06365787001, Roche). Forty-eight hours later, the medium was harvested, cleared by a 0.45-μm filter (PN4184, PALL Life Sciences), mixed with polybrene (5 μg/ml) (H9268, Sigma-Aldrich), and applied to the cells. After 6 hours of incubation, the virus-containing medium was replaced by fresh medium. Virus supernatants were tittered using the QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24, VPK-107, Cell Biolabs).
RNA isolation and quantitative real-time PCR. Cells were suspended in TRIzol Reagent (15596018, Invitrogen), and total RNA (74134, QIAGEN) was isolated according to the manufacturer's instructions. Reverse transcriptions were performed by using the iScript cDNA Synthesis Kit (170-8891, Bio-Rad). Quantitative real-time PCR (qRT-PCR) was performed using the Bio-Rad CFX94 by mixing equal amount of cDNAs, iQ SYBR Green Supermix (170-8882, Bio-Rad), and gene-specific primers from SABiosciences (a QIAGEN company) (FGFR1 and collagen 1A, tgtggcccagaagaactggt and caggaaggtcagctggatgg. All reactions were done in a 25 μl reaction volume in duplicate. Individual mRNA expression was normalized in relation to expression of endogenous β-actin. PCR amplification consisted of 10 minutes of an initial denaturation step at 95°C, followed by 46 cycles of PCR at 95°C for 15 seconds and 60°C for 30 seconds.
Antibodies used for immunodetection of proteins. We used the following antibodies for immunoblotting (IB), immunofluorescence (IF), or immunohistochemistry (IHC): CD31 (sc-1506, Santa Cruz; IHC for human and mouse paraffin samples), CD31 (sc-8306, Santa Cruz; IB), CD31 (M0823, Dako; IHC for human frozen samples), collagen 1 (600-401-103S, Rockland; IB), collagen 1 (NB600-408, Novus Biologicals; IHC), p44/42 MAPK (ERK1/2) (Thr202/Tyr204) (4370, Cell jci.org Volume 125 Number 12 December 2015
jected at final magnifications of ×40. ImageJ software (NIH) was used for morphometric analyses. As described in Supplemental Figure 8B , measurements were made of the intima and media thickness. The ratio of I/M thickness and plaque stages (38) were used to grade the severity of atherosclerosis. We averaged the results for these parameters from 4 different areas for each specimen to obtain mean values. Left main coronary arteries with an I/M ratio of less than 0.2 were considered as having no disease or mild disease; those with an I/M ratio of between 0.2 and 1 were considered as having moderate disease; those with an I/M ratio of greater than 1 or with calcification were considered as having severe disease.
Statistics. All graphs were created using GraphPad Prism software, and statistical analyses were calculated using GraphPad Prism. The significance of the differences between the controls and the experimental groups was determined using a 2-tailed Student's t test. For multiple comparisons, 1-way ANOVA with Newman-Keuls test was used. Correlation analyses between variables were performed using the Pearson rank correlation test. A P value of less than 0.05 was considered significant. All results were confirmed by at least 3 independent experiments. Error bars represent mean ± SEM.
Study approval. All experiments involving animals were reviewed and approved by the Yale University Institutional Animal Care and Use Committee. The procedures related to human subjects were approved by the Institutional Review Boards of Yale University and the New England Organ Bank. A waiver for consent was approved for surgical patients, and written informed consent was obtained from a member of the family for deceased organ donors.
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